126 related articles for article (PubMed ID: 7493601)
1. Behavioural response to SKF 38393 and quinpirole following chronic antidepressant treatment.
Allison K; Ivanová S; Greenshaw AJ
Eur J Pharmacol; 1995 Apr; 277(2-3):139-44. PubMed ID: 7493601
[TBL] [Abstract][Full Text] [Related]
2. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
Ainsworth K; Smith SE; Sharp T
J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
[TBL] [Abstract][Full Text] [Related]
3. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
Garrett BE; Holtzman SG
Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
[TBL] [Abstract][Full Text] [Related]
4. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
Neisewander JL; Lucki I; McGonigle P
Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
6. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding.
Allison K; Paetsch PR; Baker GB; Greenshaw AJ
Eur J Pharmacol; 1993 Nov; 249(2):125-31. PubMed ID: 8287894
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence.
Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
Psychopharmacology (Berl); 1995 Jan; 117(1):82-90. PubMed ID: 7724706
[TBL] [Abstract][Full Text] [Related]
8. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
9. The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(3):287-97. PubMed ID: 7770604
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.
Wu M; Brudzynski SM; Mogenson GJ
Brain Res Bull; 1993; 32(4):395-8. PubMed ID: 8106125
[TBL] [Abstract][Full Text] [Related]
11. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
Maj J; Papp M; Skuza G; Bigajska K; Zazula M
J Neural Transm; 1989; 76(1):29-38. PubMed ID: 2565359
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.
Rimondini R; Ferré S; Giménez-Llort L; Ogren SO; Fuxe K
Eur J Pharmacol; 1998 Apr; 347(2-3):153-8. PubMed ID: 9653875
[TBL] [Abstract][Full Text] [Related]
13. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
[TBL] [Abstract][Full Text] [Related]
14. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
[TBL] [Abstract][Full Text] [Related]
15. Intra-medial prefrontal cortex injection of quinpirole, but not SKF 38393, blocks the acute motor-stimulant response to cocaine in the rat.
Beyer CE; Steketee JD
Psychopharmacology (Berl); 2000 Aug; 151(2-3):211-8. PubMed ID: 10972467
[TBL] [Abstract][Full Text] [Related]
16. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
Saigusa T; Koshikawa N; Kitamura M; Mizutani K; Kobayashi M; Cools AR
Eur J Pharmacol; 1995 Feb; 274(1-3):213-20. PubMed ID: 7539377
[TBL] [Abstract][Full Text] [Related]
17. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
Cauli O; Morelli M
Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
[TBL] [Abstract][Full Text] [Related]
18. Ontogenetic quinpirole treatment induces vertical jumping activity in rats.
Kostrzewa RM; Guo J; Kostrzewa FP
Eur J Pharmacol; 1993 Aug; 239(1-3):183-7. PubMed ID: 7901028
[TBL] [Abstract][Full Text] [Related]
19. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
Subramaniam S; Lucki I; McGonigle P
Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
